National Cancer Institute-IRCCS "Fondazione G. Pascale"

Naples 80131

0 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumor, Dedifferentiated Liposarcoma, Gynecologic Cancer, HER2+ Metastatic Breast Cancer (MBC), HPV16 Positive, Squamous Cell Carcinoma of the Oropharynx

Studies at this site

• Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma — Stopped early
• A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC — Status unconfirmed
• A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor — Paused
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed